Welcome to LookChem.com Sign In|Join Free

CAS

  • or

51336-94-8

Post Buying Request

51336-94-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2-Chloro-2',4'-difluoroacetophenone CAS 51336-94-8 2-Chloro-1-(2,4-difluorophenyl)ethanone CAS no 51336-94-8 Ethanone,2-chloro-1-(2,4-difluorophenyl)-

    Cas No: 51336-94-8

  • USD $ 3.5-5.0 / Kiloliter

  • 5 Kiloliter

  • 3000 Metric Ton/Month

  • Chemwill Asia Co., Ltd.
  • Contact Supplier

51336-94-8 Usage

Description

2-Chloro-2',4'-difluoroacetophenone is an organic compound characterized by its white crystalline powder appearance. It is a derivative of α-haloacetophenone, which is known for its potential applications in various chemical and pharmaceutical processes.

Uses

Used in Pharmaceutical Applications:
2-Chloro-2',4'-difluoroacetophenone is used as an inhibitor for protein tyrosine phosphatases SHP-1 and PTP1B. These phosphatases play a crucial role in various cellular processes, and their inhibition can have significant implications in the development of therapeutic strategies for various diseases.
Used in Chemical Synthesis:
In the chemical industry, 2-Chloro-2',4'-difluoroacetophenone is utilized in the synthesis of allyl alcohol. This versatile compound serves as a building block for the creation of various organic compounds and materials, contributing to the development of new products and technologies.
Used in Research and Development:
Due to its unique chemical properties, 2-Chloro-2',4'-difluoroacetophenone is also employed in research and development settings. It is used to study the interactions and effects of α-haloacetophenone derivatives on protein tyrosine phosphatases, which can lead to a better understanding of their role in cellular processes and potential applications in medicine.

Check Digit Verification of cas no

The CAS Registry Mumber 51336-94-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,3,3 and 6 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 51336-94:
(7*5)+(6*1)+(5*3)+(4*3)+(3*6)+(2*9)+(1*4)=108
108 % 10 = 8
So 51336-94-8 is a valid CAS Registry Number.

51336-94-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (B22487)  2-Chloro-2',4'-difluoroacetophenone, 98%   

  • 51336-94-8

  • 5g

  • 502.0CNY

  • Detail
  • Alfa Aesar

  • (B22487)  2-Chloro-2',4'-difluoroacetophenone, 98%   

  • 51336-94-8

  • 25g

  • 2472.0CNY

  • Detail

51336-94-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Chloro-2',4'-difluoroacetophenone

1.2 Other means of identification

Product number -
Other names 2-Chloro-1-(2,4-difluorophenyl)ethanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51336-94-8 SDS

51336-94-8Relevant articles and documents

Discovery of potential antifungal triazoles: Design, synthesis, biological evaluation, and preliminary antifungal mechanism exploration

Zhang, Yuan,Damu, Guri L. V.,Cui, Sheng-Feng,Mi, Jia-Li,Tangadanchu, Vijai Kumar Reddy,Zhou, Cheng-He

, p. 1631 - 1639 (2017)

A series of triazoles as miconazole analogues was designed, synthesized and characterized by IR, NMR, MS and HRMS. All the newly prepared compounds were screened for their antifungal activities against five kinds of fungi. The bioactive assay showed that most of the synthesized compounds exhibited good or even stronger antifungal activities in comparison with the reference drugs miconazole and fluconazole. In particular, the 3,4-dichlorobenzyl derivative 5b showed a comparable or superior activity against all the tested fungal strains to standard drugs, and formed a supramolecular complex with CYP51 via the hydrogen bond between the 4-nitrogen of the triazole nucleus and the histidine residue. Preliminary experiments revealed that both of the active molecules 5b and 9c could intercalate into calf thymus DNAs, which might block DNA replication to exhibit their powerful antifungal abilities. Further studies indicated that compound 5b might be stored and transported by human serum albumin through hydrophobic interactions, specific electrostatic interactions and hydrogen bonds. These results strongly suggested that compound 5b could serve as a promising antifungal candidate.

Design, synthesis, and biological evaluation of novel miconazole analogues containing selenium as potent antifungal agents

An, Ran,Guo, Chun,Guo, Meng-bi,Hou, Zhuang,Mou, Yan-hua,Su, Xin,Xu, Hang

, (2020/05/11)

Herein, based on the theory of bioisosterism, a series of novel miconazole analogues containing selenium were designed, synthesized and their inhibitory effects on thirteen strains of pathogenic fungi were evaluated. It is especially encouraging that all the novel target compounds displayed significant antifungal activities against all tested strains. Furthermore, all the target compounds showed excellent inhibitory effects on fluconazole-resistant fungi. Subsequently, preliminary mechanistic studies indicated that the representative compound A03 had a strong inhibitory effect on C.alb. CYP51. Moreover, the target compounds could prevent the formation of fungi biofilms. Further hemolysis test verified that potential compounds had higher safety than miconazole. In addition, molecular docking study provided the interaction modes between the target compounds and C.alb. CYP51. These results strongly suggested that some target compounds are promising as novel antifungal drugs.

Continuous Flow Synthesis of Terminal Epoxides from Ketones Using in Situ Generated Bromomethyl Lithium

Von Keutz, Timo,Cantillo, David,Kappe, C. Oliver

supporting information, p. 10094 - 10098 (2019/12/24)

A scalable procedure for the direct preparation of epoxides from ketones has been developed. The method is based on the carefully controlled generation of (bromomethyl)lithium (LiCH2Br) from inexpensive CH2Br2 and MeLi in a continuous flow reactor. The reaction has shown excellent selectivity for a variety of substrates, including α-chloroketones, which typically fail under classic Corey-Chaykovsky conditions. This advantage has been used to develop a novel route toward the drug fluconazole.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51336-94-8